Global and United States New Traditional Chinese Medicine Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and United States New Traditional Chinese Medicine Market Report & Forecast 2024-2034
New Traditional Chinese Medicine refers to a new type of medicine developed through innovative research and development based on traditional Chinese medicine or Chinese herbal formulations. It may contain not only the traditional Chinese medicine ingredients, but also synthetic chemical Compounds or natural substances, as well as processed and extracted Chinese medicine ingredients. The research and development of Chinese medicine innovative drugs follows the standards and procedures of modern drug development, using modern scientific techniques to screen, extract, and isolate the ingredients of Chinese herbal formula ations in order to achieve more significant therapeutic effects, fewer side effects, and better absorption and utilization by the human body. The development of these drugs plays an important role in promoting the modernization and internationalization of traditional Chinese medicine.
Market Analysis and InsightsGlobal and United States New Traditional Chinese Medicine Market
This report focuses on global and United States New Traditional Chinese Medicine market, also covers the segmentation data of other regions in regional level and county level.
The global New Traditional Chinese Medicine revenue was US$ 3561 million in 2022 and is forecast to a readjusted size of US$ 5072.6 million by 2034 with a CAGR of 5.3% during the review period (2024-2034).
In United States the New Traditional Chinese Medicine revenue is expected to grow from US$ million in 2022 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of New Traditional Chinese Medicine include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. The global five biggest players hold a share of % in 2022.
Global New Traditional Chinese Medicine Scope and Market Size
New Traditional Chinese Medicine market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global New Traditional Chinese Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the New Traditional Chinese Medicine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Fangsheng Pharma
BaiYunShan
Segment by Type
Innovative Traditional Chinese Medicine
Improved New Drug of Traditional Chinese Medicine
Traditional Chinese Medicine Compound Preparation
Online Sales
Offline Sales
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces New Traditional Chinese Medicine definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of New Traditional Chinese Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of New Traditional Chinese Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, New Traditional Chinese Medicine revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States New Traditional Chinese Medicine Market
This report focuses on global and United States New Traditional Chinese Medicine market, also covers the segmentation data of other regions in regional level and county level.
The global New Traditional Chinese Medicine revenue was US$ 3561 million in 2022 and is forecast to a readjusted size of US$ 5072.6 million by 2034 with a CAGR of 5.3% during the review period (2024-2034).
In United States the New Traditional Chinese Medicine revenue is expected to grow from US$ million in 2022 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of New Traditional Chinese Medicine include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. The global five biggest players hold a share of % in 2022.
Global New Traditional Chinese Medicine Scope and Market Size
New Traditional Chinese Medicine market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global New Traditional Chinese Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the New Traditional Chinese Medicine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.
By Company
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Fangsheng Pharma
BaiYunShan
Segment by Type
Innovative Traditional Chinese Medicine
Improved New Drug of Traditional Chinese Medicine
Traditional Chinese Medicine Compound Preparation
Segment by Application
Online Sales
Offline Sales
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces New Traditional Chinese Medicine definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of New Traditional Chinese Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of New Traditional Chinese Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, New Traditional Chinese Medicine revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices